ADM and Cowden disease: In animal CD models, DKT has been shown to either directly or indirectly reduce inflammation and restore the blood flow to ischemic segments of the colon by promoting endogenous adrenomedullin (ADM) release, thereby contributing to the prevention of disease recurrence [10–12].